Abstract
BReast CAncer gene 1 (BRCA1)—a tumor suppressor gene plays an important role in the DNA repair mechanism. Several BRCA1 variants perturb its structure and function, including synonymous and nonsynonymous single nucleotide polymorphisms (SNPs). In the present study, we performed in-silico analyses of nonsynonymous SNPs (nsSNPs) of the BRCA1 gene. In total, 122 nsSNPs were retrieved from the NCBI SNP database and in-silico analyses were performed using computational prediction tools: SIFT, PROVEAN, Mutation Taster, PolyPhen-2, MutPred, and ConSurf. Of these tools, SIFT, PROVEAN, and Mutation Taster predicted 61 out of 122 nsSNPs as “damaging”, based on structural homology analysis. PolyPhen-2 classified 22 nsSNPs as “probably damaging”. These nsSNPs were further analyzed by MutPred to predict basic molecular mechanisms of amino acid alteration. ConSurf analysis predicted eleven conserved amino acid residues with structural and functional consequences. We identified five amino acid residues in the RING finger domain (L22, C39, H41, C44, and C47) and two in the BRCT domain (P1771 and I1707) with the potential to deter the BRCA1 protein function. This study provides insights into the effect of nsSNPs and amino acid substitutions in BRCA1.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Change history
27 November 2021
A Correction to this paper has been published: https://doi.org/10.1007/s10528-021-10161-9
References
Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 76:7–20. https://doi.org/10.1002/0471142905.hg0720s76
Brzovic PS, Meza JE, King MC, Klevit RE (2001a) BRCA1 RING domain cancer-predisposing mutations structural consequences and effects on protein-protein interactions. J Biol Chem 276:41399–41406. https://doi.org/10.1074/jbc.M106551200
Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE (2001b) Structure of a BRCA1–BARD1 heterodimeric RING–RING complex. Nat Struct Biol 8:833–837. https://doi.org/10.1038/nsb1001-833
Clark SL, Rodriguez AM, Snyder RR, Hankins GD, Boehning D (2012) Structure-function of the tumor suppressor BRCA1. Comput Struct Biotechnol J 1(1):e201204005. https://doi.org/10.5936/csbj.201204005
Densham RM, Morris JR (2017) The BRCA1 Ubiquitin ligase function sets a new trend for remodelling in DNA repair. Nucleus 8:116–125. https://doi.org/10.1080/19491034.2016.1267092
Dietlein F, Thelen L, Reinhardt HC (2014) Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches. Trends Genet 30:326–339. https://doi.org/10.1016/j.tig.2014.06.003
Ernst C, Hahnen E, Engel C, Nothnagel M, Weber J, Schmutzler RK, Hauke J (2018) Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics. BMC Med Genom 11:35. https://doi.org/10.1186/s12920-018-0353-y
Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122. https://doi.org/10.1038/ng0696-238
Ghafouri-Fard S, Dianatpour A, Faramarzi S (2018) Meta-analysis of BRCA1 polymorphisms and breast cancer susceptibility. Klin Onkol 31:330–338. https://doi.org/10.14735/amko2018330
Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D, Martz E, Ben-Tal N (2003) ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19:163–164. https://doi.org/10.1093/bioinformatics/19.1.163
Griffiths AJ, Gelbart WM, Lewontin RC, Miller JH (2002) Modern genetic analysis: integrating genes and genomes. W. H Freeman and Company, New York
Hu J, Ng PC (2013) SIFT Indel: predictions for the functional effects of amino acid insertions/deletions in proteins. PLoS ONE 8:e77940. https://doi.org/10.1371/journal.pone.0077940
Huen MS, Sy SM, Chen J (2010) BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 11:138–148. https://doi.org/10.1038/nrm2831
Kais Z, Chiba N, Ishioka C, Parvin J (2012) Functional differences among BRCA1 missense mutations in the control of centrosome duplication. Oncogene 31:799–804. https://doi.org/10.1038/onc.2011.271
Kobayashi H, Ohno S, Sasaki Y, Matsuura M (2013) Hereditary breast and ovarian cancer susceptibility genes. Oncol Rep 30:1019–1029. https://doi.org/10.3892/or.2013.2541
Lin D, Izadpanah R, Braun SE, Alt E (2018) A novel model to characterize structure and function of BRCA1. Cell Biol Int 42:34–44. https://doi.org/10.1002/cbin.10846
Mangia A, Malfettone A, Simone G, Darvishian F (2011) Old and new concepts in histopathological characterization of familial breast cancer. Annal Oncol 22:i24–i30. https://doi.org/10.1093/annonc/mdq662
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71. https://doi.org/10.1126/science.7545954
Mort M, Sterne-Weiler T, Li B, Ball EV, Cooper DN, Radivojac P, Sanford JR, Mooney SD (2014) MutPred splice: machine learning-based prediction of exonic variants that disrupt splicing. Genome Biol 15:R19. https://doi.org/10.1186/gb-2014-15-1-r19
Pace CN, Fu H, Fryar KL, Landua J, Trevino SR, Shirley BA, Hendricks MM, Iimura S, Gajiwala K, Scholtz JM, Grimsley GR (2011) Contribution of hydrophobic interactions to protein stability. J Mol Biol 408:514–528. https://doi.org/10.1016/j.jmb.2011.02.053
Palmero EI, Carraro DM, Alemar B, Moreira MAM, Ribeiro-dos-Santos Â, Abe-Sandes K et al (2018) The germline mutational landscape of BRCA1 and BRCA 2 in Brazil. Sci Rep 8:1–10. https://doi.org/10.1038/s41598-018-27315-2
Pirim D, Kaya N, Yıldırım EU, Sag SO, Temel SG (2020) Characterization and in silico analyses of the BRCA1/2 variants identified in individuals with personal and/or family history of BRCA-related cancers. Int J Biol Macromol 162:1166–1177. https://doi.org/10.1016/j.ijbiomac.2020.06.222
Poteete AR, Rennell D, Bouvier SE (1992) Functional significance of conserved amino acid residues. Proteins 13:38–40. https://doi.org/10.1002/prot.340130104
Rajasekaran R, Sudandiradoss C, Doss CGP, Sethumadhavan R (2007) Identification and in silico analysis of functional SNPs of the BRCA1 gene. Genomics 90:447–452. https://doi.org/10.1016/j.ygeno.2007.07.004
Rashid MU, Gull S, Asghar K, Muhammad N, Amin A, Hamann U (2012) Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients. Fam Cancer 11:307–311. https://doi.org/10.1007/s10689-012-9509-7
Rashid MU, Muhammad N, Faisal S, Amin A, Hamann U (2013) Constitutional CHEK2mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan. BMC Cancer 13:312. https://doi.org/10.1186/1471-2407-13-312
Rosen EM (2013) BRCA1 in the DNA damage response and at telomeres. Front Genet 4:85. https://doi.org/10.3389/fgene.2013.00085
Roy R, Chun J, Powell SN (2012) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 12:68–78. https://doi.org/10.1038/nrc3181
Thangaraju M, Kaufmann SH, Couch FJ (2000) BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J Biol Chem 275:33487–33496. https://doi.org/10.1074/jbc.M005824200
Towler WI, Zhang J, Ransburgh DJ, Toland AE, Ishioka C, Chiba N, Parvin JD (2013) Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing. Hum Mutat 34:439–445. https://doi.org/10.1002/humu.22251
Wu J, Lu LY, Yu X (2010) The role of BRCA1 in DNA damage response. Protein Cell 1:117–123. https://doi.org/10.1007/s13238-010-0010-5
Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX (2001) Genetic interactions between tumor suppressors BRCA1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet 28:266–271. https://doi.org/10.1038/90108
Yadegari F, Farahmand L, Esmaeili R, Zarinfam S, Majidzadeh AK (2019) Functional investigation of the novel BRCA1 variant (Glu1661Gly) by computational tools and yeast transcription activation assay. Mol Biol Res Commun 3:20–26. https://doi.org/10.22099/mbrc.2019.33971.1414
Yadegari F, Majidzadeh K (2019) In silico analysis for determining the deleterious nonsynonymous single nucleotide polymorphisms of BRCA genes. Mol Biol Res Commun 8:141–150. https://doi.org/10.22099/mbrc.2019.34198.1420
Yuan Z, Li J, Li J, Zhang L, Gao X, Gao HJ, Xu S (2012) Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene 505:190–194. https://doi.org/10.1016/j.gene.2012.05.010
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
SA: methodology, data acquisition and analysis, original draft preparation, II: computational analysis, data interpretation; SA: methodology, data analysis; MUR: supervising, writing, reviewing and proof reading of manuscript; NM: conceptualization, supervision, writing-reviewing and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Arshad, S., Ishaque, I., Mumtaz, S. et al. In-Silico Analyses of Nonsynonymous Variants in the BRCA1 Gene. Biochem Genet 59, 1506–1526 (2021). https://doi.org/10.1007/s10528-021-10074-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-021-10074-7